Sanofi Genzyme

Sanofi Genzyme, Alnylam Pharmaceuticals: APOLLO Phase 3 study of patisiran met its primary efficacy endpoint and all secondary endpoints

Investigational RNAi Therapeutic Patisiran Meets Primary and All Secondary Endpoints, with Highly Significant Reduction In Neuropathy Progression and Improvement in…

7 years ago